Hospira UK Ltd

Queensway, Royal Leamington Spa, Warwickshire, CV31 3RW
Telephone: +44 (0)1926 820 820
Fax: +44 (0) 1926 834446
WWW: http://www.hospira.com
Medical Information Direct Line: +44 (0) 1926 834400
Medical Information e-mail: medinfouk@hospira.com
Customer Care direct line: +44 (0)1926 821 022
Patient Information Leaflet last updated on the eMC: 20/11/2009
PIL Irinotecan Hydrochloride 20 mg/ml Concentrate for Solution for Infusion

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 20/11/2009 and displayed until Current
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
  • Correction of spelling/typing errors
  • Change to, or new, use for medicine
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to instructions about overdose
  • Change to storage instructions
  • Change to side-effects
  • Change to drug interactions
  • Change to information about pregnancy or lactation
  • Change to information about driving or using machinery
  • Change to dosage and administration
  • Changes to therapeutic indications
Updated on 25/03/2009 and displayed until 20/11/2009
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
   irinotecan hydrochloride trihydrate


© 2010 Datapharm Communications Ltd

Go to www.medicines.org.uk